BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29785022)

  • 1. Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer.
    Lei Z; Chai N; Tian M; Zhang Y; Wang G; Liu J; Tian Z; Yi X; Chen D; Li X; Yu P; Hu H; Xu B; Jian C; Bian Z; Guo H; Wang J; Peng S; Nie Y; Huang N; Hu S; Wu K
    Cell Death Dis; 2018 May; 9(6):579. PubMed ID: 29785022
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yin J; Xin B; Hui X; Chai N; Yao L; Hu H; Xu B; Ma W; Zhang M; Wang J; Nie Y; Zhou G; Wang G; Chen L; Lu H; Wu K
    Eur J Pharm Biopharm; 2020 Sep; 154():144-152. PubMed ID: 32682942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy.
    Chen B; Cao S; Zhang Y; Wang X; Liu J; Hui X; Wan Y; Du W; Wang L; Wu K; Fan D
    BMC Cell Biol; 2009 Sep; 10():63. PubMed ID: 19740430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
    Cho SY; Oh Y; Jeong EM; Park S; Lee D; Wang X; Zeng Q; Qin H; Hu F; Gong H; Liu X; Zhang G; Na D; Lee J; Chae J; Suh YS; Kong SH; Lee HJ; Kim JI; Park H; Zhang C; Yang HK; Lee C
    Exp Mol Med; 2020 May; 52(5):854-864. PubMed ID: 32467608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GX1-mediated anionic liposomes carrying adenoviral vectors for enhanced inhibition of gastric cancer vascular endothelial cells.
    Xiong D; Liu Z; Bian T; Li J; Huang W; Jing P; Liu L; Wang Y; Zhong Z
    Int J Pharm; 2015 Dec; 496(2):699-708. PubMed ID: 26570987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC.
    Hui X; Han Y; Liang S; Liu Z; Liu J; Hong L; Zhao L; He L; Cao S; Chen B; Yan K; Jin B; Chai N; Wang J; Wu K; Fan D
    J Control Release; 2008 Oct; 131(2):86-93. PubMed ID: 18700158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality.
    Zhang L; Li Q; Yang J; Xu P; Xuan Z; Xu J; Xu Z
    Cancer Commun (Lond); 2023 Jan; 43(1):123-149. PubMed ID: 36353796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
    Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
    Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
    Shi J; Lu Y; Wei P
    J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.
    Caffarel MM; Chattopadhyay A; Araujo AM; Bauer J; Scarpini CG; Coleman N
    J Pathol; 2013 Oct; 231(2):168-79. PubMed ID: 23765377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
    Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Kang S; Oh SC; Min BW; Lee DH
    Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
    Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
    Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.
    Erdem M; Erdem S; Sanli O; Sak H; Kilicaslan I; Sahin F; Telci D
    Urol Oncol; 2014 Jan; 32(1):25.e13-20. PubMed ID: 23499501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
    Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer.
    Chen Y; Huang Y; Huang Y; Xia X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Re OD; Li G; Zhou J
    Carcinogenesis; 2014 Feb; 35(2):442-51. PubMed ID: 24072772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
    Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
    Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.